Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese <it>db/db</it> mice

<p>Abstract</p> <p>Background</p> <p>Telmisartan is a well-established angiotensin II type 1 receptor blocker that improves insulin sensitivity in animal models of obesity and insulin resistance, as well as in humans. Telmisartan has been reported to function as a parti...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Shiota Asuka, Shimabukuro Michio, Fukuda Daiju, Soeki Takeshi, Sato Hiromi, Uematsu Etsuko, Hirata Yoichiro, Kurobe Hirotsugu, Maeda Norikazu, Sakaue Hiroshi, Masuzaki Hiroaki, Shimomura Iichiro, Sata Masataka
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2012-11-01
Edice:Cardiovascular Diabetology
Témata:
Adiponectin
AMP-activated protein kinase
Obesity
Peroxisome proliferator-activated receptor-γ
SIRT1
On-line přístup:http://www.cardiab.com/content/11/1/139
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky